前列腺突入膀胱对前列腺癌诊疗的影响

doi:10.3877/cma.j.issn.1674-3253.2026.04.015

作为前列腺的形态学改变，前列腺突入膀胱（IPP）常用于评估泌尿系统疾病，尤其是前列腺增生。然而，近年来越来越多研究发现IPP对前列腺癌（PCa）的诊疗有一定影响。诊断方面，IPP可辅助PCa诊断；治疗方面，IPP可能影响PCa根治效果，并发症发生率，并进一步影响预后。外科医师术前应对IPP进行精准评估，制定个体化方案，减少不良影响，挖掘其在PCa诊疗中的价值。

关键词: 前列腺癌, 前列腺突入膀胱

As a morphological alteration of the prostate, intravesical prostatic protrusion (IPP) is conventionally utilized to assess lower urinary tract symptoms, particularly in benign prostatic hyperplasia (BPH). However, a growing body of recent evidence indicates that IPP exerts a significant influence on the diagnosis and treatment of prostate cancer (PCa). Diagnostically, IPP may serve as an auxiliary indicator for PCa detection. Therapeutically, IPP can impact the efficacy of radical prostatectomy, modulate postoperative complication rates, and consequently affect long-term prognosis. Therefore, it is imperative for surgeons to conduct precise preoperative assessments of IPP and formulate individualized surgical strategies to mitigate adverse outcomes and harness the clinical utility of IPP in the management of PCa.

Key words: Prostate cancer, Intravesical prostatic protrusion

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
[2]	He S, Xia C, Li H, et al. Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors[J]. Sci China Life Sci, 2024, 67(1): 122-131. DOI: 10.1007/s11427-023-2423-1.
[3]	Martinez O, Murphy C, Bsatee A, et al. Impact of Median lobe on urinary function after robotic prostatectomy[J]. Prostate, 2021, 81(12): 832-837. DOI: 10.1002/pros.24179.
[4]	Ohnishi K, Watanabe H, Ohe H, et al. Development and clinical significance of protrusion of hypertrophic prostate into the bladder observed by transrectal ultrasonotomography[J]. Jpn J Urol, 1985, 76(8): 1194-1200. DOI: 10.5980/jpnjurol1928.76.8_1194.
[5]	Moussaoui G, Zakaria AS, Negrean C, et al. Accuracy of clarius, handheld wireless point-of-care ultrasound, in evaluating prostate morphology and volume compared to radical prostatectomy specimen weight: is there a difference between transabdominal vs transrectal approach?[J]. J Endourol, 2021, 35(9): 1300-1306. DOI: 10.1089/end.2020.0874.
[6]	Kaplan SA. Re: intravesical prostatic protrusion as a predictor of early urinary continence recovery after laparoscopic radical prostatectomy[J]. J Urol, 2016, 195(1): 137-138. DOI: 10.1016/j.juro.2015.10.048.
[7]	Chia SJ, Heng CT, Chan SP, et al. Correlation of intravesical prostatic protrusion with bladder outlet obstruction[J]. BJU Int, 2003, 91(4): 371-374. DOI: 10.1046/j.1464-410x.2003.04088.x.
[8]	王亚申, 罗飞, 李健. 基于临床因素的tPSA 4~10 ng/ml前列腺癌风险分析[J]. 现代泌尿生殖肿瘤杂志, 2025, 17(1): 14-18. DOI: 10.3870/j.issn.1674-4624.2025.01.004.
[9]	余丽娜, 罗翠, 刘双苔, 等. 前列腺癌筛查健康信念量表的编制与信效度检验[J]. 医学新知, 2025, 35(1): 65-72. DOI: 10.12173/j.issn.1004-5511.202406044.
[10]	Kachuri L, Hoffmann TJ, Jiang Y, et al. Genetically adjusted PSA levels for prostate cancer screening[J]. Nat Med, 2023, 29(6): 1412-1423. DOI: 10.1038/s41591-023-02277-9.
[11]	陈原杰, 余天一, 李望. 前列腺健康指数联合PI-RADS评分在血清前列腺特异性抗原4~10 μg/L前列腺癌患者中的诊断价值[J]. 徐州医科大学学报, 2025, 45(2): 146-150. DOI: 10.12467/j.issn.2096-3882.20240343.
[12]	Xu D, Yu Y, Zhu Y, et al. A new model consists of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of prostate cancer[J]. Pathol Oncol Res, 2014, 20(2): 439-443. DOI: 10.1007/s12253-013-9714-1.
[13]	Simmons LAM, Kanthabalan A, Arya M, et al. Accuracy of transperineal targeted prostate biopsies, visual estimation and image fusion in men needing repeat biopsy in the PICTURE trial[J]. J Urol, 2018, 200(6): 1227-1234. DOI: 10.1016/j.juro.2018.07.001.
[14]	Rosenberg JE, Jarosek S, Spilseth B, et al. Diagnosing prostate cancer: the role of intravesical prostatic gland protrusion on accuracy of prostate biopsies[J]. J Urol, 2022, 207(6): 1207-1213. DOI: 10.1097/ju.0000000000002448.
[15]	Spohn S, Jaegle C, Fassbender TF, et al. Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients[J]. Eur J Nucl Med Mol Imaging, 2020, 47(12): 2796-2803. DOI: 10.1007/s00259-020-04827-6.
[16]	Li M, Guo J, Hu P, et al. Tomoelastography based on multifrequency MR elastography for prostate cancer detection: comparison with multiparametric MRI[J]. Radiology, 2021, 299(2): 362-370. DOI: 10.1148/radiol.2021201852.
[17]	Guo Z, Qin X, Mu R, et al. Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate[J]. J Magn Reson Imaging, 2022, 56(5): 1311-1319. DOI: 10.1002/jmri.28204.
[18]	Fletcher P, de Santis M, Ippoliti S, et al. Vector prostate biopsy: a novel magnetic resonance imaging/ultrasound image fusion transperineal biopsy technique using electromagnetic needle tracking under local anaesthesia[J]. Eur Urol, 2023, 83(3): 249-256. DOI: 10.1016/j.eururo.2022.12.007.
[19]	Kawada T, Yanagisawa T, Rajwa P, et al. Diagnostic performance of prostate-specific membrane antigen positron emission tomography-targeted biopsy for detection of clinically significant prostate cancer: a systematic review and meta-analysis[J]. Eur Urol Oncol, 2022, 5(4): 390-400. DOI: 10.1016/j.euo.2022.04.006.
[20]	Qiu DX, Li J, Zhang JW, et al. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study[J]. Eur J Nucl Med Mol Imaging, 2022, 49(8): 2821-2832. DOI: 10.1007/s00259-021-05636-1.
[21]	Meeks JJ, Zhao L, Greco KA, et al. Impact of prostate Median lobe anatomy on robotic-assisted laparoscopic prostatectomy[J]. Urology, 2009, 73(2): 323-327. DOI: 10.1016/j.urology.2008.08.484.
[22]	Tang J, Xi W, Zhu Y, et al. Clinical significance of preoperative assessment of intravesical prostatic protrusion in radical prostatectomy[J]. J Cancer, 2023, 14(15): 2889-2894. DOI: 10.7150/jca.86582.
[23]	Peyrottes A, Dariane C, Baboudjian M, et al. Anatomic factors associated with complications after radical prostatectomy: a systematic review and meta-analysis[J]. Eur Urol Oncol, 2025, 8(2): 554-570. DOI: 10.1016/j.euo.2024.10.018.
[24]	张长升, 徐涛, 张劲松, 等. PI-RADS 3分前列腺增生与前列腺癌穿刺患者的临床特征分析[J]. 现代泌尿生殖肿瘤杂志, 2025, 17(3): 167-171, 190. DOI: 10.3870/j.issn.1674-4624.2025.03.005.
[25]	Jeong CW, Lee S, Oh JJ, et al. Quantification of Median lobe protrusion and its impact on the base surgical margin status during robot-assisted laparoscopic prostatectomy[J]. World J Urol, 2014, 32(2): 419-423. DOI: 10.1007/s00345-013-1118-z.
[26]	张帆, 郝一昌, 杨斌, 等. 前列腺突入膀胱与腹腔镜根治性前列腺切除术后切缘阳性的相关性研究[J]. 中华泌尿外科杂志, 2020, 41(9): 656-660. DOI: 10.3760/cma.j.cn112330-20200409-00279.
[27]	Huang AC, Kowalczyk KJ, Hevelone ND, et al. The impact of prostate size, Median lobe, and prior benign prostatic hyperplasia intervention on robot-assisted laparoscopic prostatectomy: technique and outcomes[J]. Eur Urol, 2011, 59(4): 595-603. DOI: 10.1016/j.eururo.2011.01.033.
[28]	Srougi M, Nesrallah LJ, Kauffmann JR, et al. Urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: a randomized prospective trial[J]. J Urol, 2001, 165(3): 815-818. DOI: 10.1016/S0022-5347(05)66534-2.
[29]	Yossepowitch O, Briganti A, Eastham JA, et al. Positive surgical margins after radical prostatectomy: a systematic review and contemporary update[J]. Eur Urol, 2014, 65(2): 303-313. DOI: 10.1016/j.eururo.2013.07.039.
[30]	Hamidi N, Atmaca AF, Canda AE, et al. Does presence of a Median lobe affect perioperative complications, oncological outcomes and urinary continence following robotic-assisted radical prostatectomy?[J]. Urol J, 2018, 15(5): 248-255. DOI: 10.22037/uj.v0i0.4276.
[31]	Coelho RF, Chauhan S, Guglielmetti GB, et al. Does the presence of Median lobe affect outcomes of robot-assisted laparoscopic radical prostatectomy?[J]. J Endourol, 2012, 26(3): 264-270. DOI: 10.1089/end.2011.0132.
[32]	Jenkins LC, Nogueira M, Wilding GE, et al. Median lobe in robot-assisted radical prostatectomy: evaluation and management[J]. Urology, 2008, 71(5): 810-813. DOI: 10.1016/j.urology.2007.12.054.
[33]	Wagaskar VG, Zaytoun O, Kale P, et al. Technical tips in managing large Median lobes during robot-assisted radical prostatectomy[J]. Eur Urol Open Sci, 2022, 45: 32-37. DOI: 10.1016/j.euros.2022.08.017.
[34]	Molinari A, Simonelli G, De Concilio B, et al. Is ureteral stent placement by the transurethral approach during robot-assisted radical prostatectomy an effective option to preoperative technique?[J]. J Endourol, 2014, 28(8): 896-898. DOI: 10.1089/end.2014.0061.
[35]	Patel SR, Kaplon DM, Jarrard D. A technique for the management of a large Median lobe in robot-assisted laparoscopic radical prostatectomy[J]. J Endourol, 2010, 24(12): 1899-1901. DOI: 10.1089/end.2010.0074.
[36]	Vickers AJ, Bianco FJ, Serio AM, et al. The surgical learning curve for prostate cancer control after radical prostatectomy[J]. J Natl Cancer Inst, 2007, 99(15): 1171-1177. DOI: 10.1093/jnci/djm060.
[37]	Ma BL, Yao L, Yu W, et al. The Institute of Urology, Peking University prostatectomy score: a simple preoperative classification of prostate cancer for predicting surgical difficulty and risk[J]. Asian J Androl, 2018, 20(6): 581-586. DOI: 10.4103/aja.aja_39_18.
[38]	Chen SH, Ke ZB, Wu YP, et al. Predictors of prolonged laparoscopic radical prostatectomy and the creation of a scoring system for the duration[J]. Cancer Manag Res, 2020, 12: 8005-8014. DOI: 10.2147/CMAR.S265480.
[39]	Barakat B, Othman H, Gauger U, et al. Retzius sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (MASTER study)? a systematic review and meta-analysis[J]. Eur Urol Focus, 2022, 8(4): 1060-1071. DOI: 10.1016/j.euf.2021.08.003.
[40]	Tappero S, Dell’Oglio P, Longoni M, et al. Challenging cases in high-risk prostate cancer patients treated with Retzius-sparing robot-assisted radical prostatectomy[J]. World J Urol, 2022, 40(8): 1993-1999. DOI: 10.1007/s00345-022-04073-5.
[41]	钱佳俊, 张梦洁, 邱雪峰, 等. 保留Retzius间隙的机器人辅助根治性前列腺切除术在中叶突出患者中的优势[J]. 中国肿瘤外科杂志, 2021, 13(4): 335-339. DOI: 10.3969/j.issn.1674-4136.2021.04.005.
[42]	向豫, 李文成. 前列腺癌根治性切除术后尿失禁的新型微创治疗研究进展[J]. 现代泌尿生殖肿瘤杂志, 2025, 17(3): 212-216. DOI: 10.3870/j.issn.1674-4624.2025.03.017.
[43]	Gu Z, Zheng Z, Zhang W, et al. The development and assessment of a predicting nomogram for the recovery of immediate urinary continence following laparoscopic radical prostatectomy[J]. Front Surg, 2022, 9: 1071093. DOI: 10.3389/fsurg.2022.1071093.
[44]	Zhang F, Chu H, Hao Y, et al. Preoperative predictive model of early urinary continence recovery after laparoscopic radical prostatectomy[J]. World J Urol, 2023, 41(1): 59-65. DOI: 10.1007/s00345-022-04198-7.
[45]	van Dijk-de Haan MC, Boellaard TN, Tissier R, et al. Value of different magnetic resonance imaging-based measurements of anatomical structures on preoperative prostate imaging in predicting urinary continence after radical prostatectomy in men with prostate cancer: a systematic review and meta-analysis[J]. Eur Urol Focus, 2022, 8(5): 1211-1225. DOI: 10.1016/j.euf.2022.01.015.
[46]	Yang B, Zhang F, Xiao C, et al. Impact of preoperative magnetic resonance imaging anatomic features on urinary continence recovery after laparoscopic radical prostatectomy[J]. Urol Int, 2020, 104(3-4): 239-246. DOI: 10.1159/000506021.
[47]	Rajih E, Meskawi M, Alenizi AM, et al. Perioperative predictors for post-prostatectomy urinary incontinence in prostate cancer patients following robotic-assisted radical prostatectomy: Long-term results of a Canadian prospective cohort[J]. J De L’association Des Urol Du Can, 2019, 13(5): E125-E131. DOI: 10.5489/cuaj.5356.
[48]	Peigne C, Fournier G, Dissaux G, et al. Minimal channel GreenLight photovaporization before permanent implant prostate brachytherapy for patients with obstructive symptoms: Technically feasible and safe[J]. Brachytherapy, 2021, 20(1): 50-57. DOI: 10.1016/j.brachy.2020.08.003.
[49]	Muraki K, Hattori C, Ogo E, et al. Analysis of radioactive implant migration in patients treated with iodine-125 seeds for permanent prostate brachytherapy with MRI-classified Median lobe hyperplasia[J]. Jcb, 2021: 254-262. DOI: 10.5114/jcb.2021.105944.
[50]	Bae HJ, Mian O, Vaidya D, et al. Use of 5-alpha-reductase inhibitors as alternatives to luteinizing-hormone releasing hormone (LHRH) analogs or anti-androgens for prostate downsizing before brachytherapy[J]. Pract Radiat Oncol, 2018, 8(3): e159-e165. DOI: 10.1016/j.prro.2017.10.004.

[1]	郭任博, 邹本奎, 边家盛. 转移性激素敏感性前列腺癌治疗决策及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(04): 373-382.
[2]	梁前俊, 李昊, 张家龙, 邰胜, 梁朝朝. 国产精锋单孔机器人在中高危前列腺癌患者中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(04): 413-419.
[3]	陈莉莉, 曾雨欣, 李军. 前列腺癌疾病负担及早期防控策略分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(03): 255-260.
[4]	杨轶, 廖新惠, 陈杰青, 吴建挺, 张仲富, 韩晓红, 梅红兵. 机器人辅助腹腔镜对比腹腔镜前列腺癌根治术：一项针对低、中危前列腺癌患者的回顾性研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 197-201.
[5]	李俊杰, 董培, 姚成, 刘泽, 李勇. 前列腺癌免疫治疗的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 209-215.
[6]	张天阳, 王星博, 王江平. 腹腔镜下前列腺癌根治术结合尿道重建技术的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 216-220.
[7]	贺慷, 杨诚, 刘存东. 经膀胱入路单孔腹腔镜技术在泌尿外科的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(02): 140-146.
[8]	李勇义, 赵均雄, 郭建东, 李文萱, 孟占鳌, 覃杰, 陈涵潇. 瘤体-瘤周细胞外容积模型对前列腺癌的诊断价值[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 56-64.
[9]	蒋钟吉, 郭洪, 王东文. 近红外显影技术在前列腺癌淋巴组织显影及病理评估中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 8-14.
[10]	梅昊楠, 杨瑞, 刘修恒. 人工智能辅助病理学图像分析在前列腺癌诊断中的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 1-7.
[11]	刘辉, 谢周洲, 周晓琪, 张桂豪, 江惠明, 陈南辉. 靶向SOAT1对前列腺癌的作用和机制研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 95-101.
[12]	覃桂林, 赵善超, 陈明坤. 人口老龄化背景下中国前列腺癌的疾病负担与筛查策略分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 102-107.
[13]	田超, 黄若曦, 蒋茂林, 谢崇伟, 刁鹏飞, 钟苏权, 陈东, 王航涛, 陈桂柳, 陈虞娟, 李国良. 不同亚型前列腺癌新辅助化疗后盆腔淋巴结转移的风险因素及时间分布[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(06): 727-735.
[14]	蒋林岑, 韩坤, 郭轩宇, 李云帆, 邱仕麟, 唐永吉, 张金栋, 王德林. 免穿刺影像引导机器人前列腺根治性剜除术临床应用[J/OL]. 中华腔镜外科杂志(电子版), 2026, 19(01): 9-16.
[15]	汪炜, 孙璇, 嵇宏声, 王苏贵, 姜福金. 染料木黄酮作用于异质性细胞核核糖蛋白A2B1抑制前列腺癌进展的研究及其下游基因的筛选[J/OL]. 中华临床医师杂志(电子版), 2026, 20(04): 301-310.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

The impact of intravesical prostatic protrusion on the diagnosis and treatment of prostate cancer

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

The impact of intravesical prostatic protrusion on the diagnosis and treatment of prostate cancer